Product Information
KETOROLAC 15 MG/ML VIAL is a generic product labeled by Caplin Steriles Limited, priced at $0.9459 per ML under NDC 65145014625. Its NADAC has been published 47 times since Mar 26, 2025.
FDA first approved this application on May 10, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
15 mg/mL
Manufacturer
Caplin Steriles LimitedNDC
65145014625
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
3/26/2025
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA217789FDA Approved
5/10/2023
TE Code
AP
On Market Since
10/4/2024
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 15 MG/ML VIAL has been published 47 times since Mar 26, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9459 per ML |
|---|---|
| All-time high | $0.9459 (Feb 11, 2026) |
| All-time low | $0.9459 (Mar 26, 2025) |
| 52-week high | $0.9459 |
| 52-week low | $0.9459 |
| Median price | $0.9459 |
| Average price | $0.9459 |
| Largest weekly change | 0.0% (Apr 2, 2025) |
| Weeks tracked | 47 |
| Tracking since | Mar 26, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Caplin Steriles Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketorolac tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 15 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 15 MG/ML VIAL, manufactured by Caplin Steriles Limited, is $0.9459 per ML (NDC 65145014625), effective Feb 11, 2026.
How has the price of KETOROLAC 15 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 15 MG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 47 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for KETOROLAC 15 MG/ML VIAL?
Since Mar 26, 2025, the NADAC for KETOROLAC 15 MG/ML VIAL has ranged from a low of $0.9459 (Mar 26, 2025) to a high of $0.9459 (Feb 11, 2026), with a median of $0.9459 per ML.
Are there cheaper alternatives to KETOROLAC 15 MG/ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 15 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 15 MG/ML VIAL?
KETOROLAC 15 MG/ML VIAL (NDC 65145014625) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.